[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338443-105":59,"doc-detail-338443-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","hematological-changes-in-women-with-cervical-cancer-before-and-after-cancer-treatment-retrospective-cohort-study","Hematological changes in women with cervical cancer before and after cancer treatment: retrospective cohort study","","Hematological changes are a common complication in cervical cancer, arising from disease processes and treatment-related adverse effects. This retrospective cohort study assessed hematological toxicity in women with cervical cancer before and after treatment initiation at the University of Gondar Comprehensive Specialized Hospital between 2015 and 2022. Hematological profiles and sociodemographic and clinical variables were analyzed using descriptive statistics, Wilcoxon rank tests, and logistic regression. Hemoglobin, white blood cells, and platelet counts changed significantly after chemo-radiotherapy and surgery, with stage-related risk increases. Routine monitoring and screening for major risk factors were emphasized.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/hematological-changes-in-women-with-cervical-cancer-before-and-after-cancer-treatment-retrospective-cohort-study/338443/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/hematological-changes-in-women-with-cervical-cancer-before-and-after-cancer-treatment-retrospective-cohort-study/338443.png","ImageObject",300,407,{"name":92,"@type":93},"Quinn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main purpose of the study?","Question",{"text":112,"@type":113},"To assess hematological toxicity in women with cervical cancer before and after initiation of treatment, using a retrospective cohort design.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which statistical methods were used to compare and model hematological parameters?",{"text":117,"@type":113},"Descriptive statistics summarized data; Wilcoxon rank test compared median differences before and after treatment; logistic regression assessed independent associations between hematological abnormalities and variables.",{"name":119,"@type":110,"acceptedAnswer":120},"How did hematological abnormalities change after treatment?",{"text":121,"@type":113},"After treatment, hemoglobin, white blood cell counts, and platelet counts were significantly lowered, while red cell distribution width increased. Anemia increased after treatment, and leucocytosis/thrombocytosis patterns shifted to leucopenia/thrombocytopenia.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338443,1790507740,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nHematological changes in women with cervical cancer before and after cancer treatment:  \nretrospective cohort study  \nDereje Mengesha Berta1􀀍, Bisrat Birke Teketelew1, Elias Chane2, Biruk Bayleyegn1,  \nMebratuTamir3, Negesse Cherie4, Masiresha Seyoum1, Amare Mekuanint2 & MelakAynalem1 Hematological changes is one of the most common complications occurred in cancer patients.  \nTherefore, the current study aimed to assess the hematological toxicity of cervical cancer patients before and after the initiation of treatment. The retrospective cohort study was conducted from 2015 to 2022 atthe University of Gondar Comprehensive Specialized Hospital. The hematological profile and sociodemographic and clinical data of the cervical cancer patients were collected using data extraction sheets. The Epidata version 3.1 and SPSS version 25 were used for data entry and analysis, respectively. Descriptive statistics were employed to summarize the data. To compare the median differences in hematological parameters before and after treatment, the Wilcoxon rank test was used. In addition, to assess the presence of an independent association between hematological abnormalities and the independent variables, logistic regression models were used. A p value less than 0.05 was considered to indicate statistical significance for all tests. In current study, the median (Interquartile range) of hemoglobin levels, white blood cell counts, and platelet counts, before treatment were 13.2 (12.1, 15) g/dl, 7.5 (5.8, 11.8) *109/L, and 330 (252, 383) *109/L, respectively. However, after treatment the median (Interquartile range) value of hemoglobin levels, white blood cell counts, and platelet counts were significantly lowered. On the other hand, red cell distribution width was significantly greater after treatment. At baseline, the magnitude of leucocytosis, anemia, and thrombocytosis were 27.9%, 24.6%, and 18.7%, respectively. After the treatment, anemia increased to 44.3%, but leucocytosis and thrombocytosis were replaced by leucopenia 18.3% and thrombocytopenia 17.8%, respectively. Hematological abnormalities such as anemia, leucopenia and thrombocytopenia were high after chemo-radiotherapy, and surgery. Asthe stage of cancer advances, the risk of developing anemia, leucocytosis, and thrombocytosis increased in 7.6, 6.9 and 9 times, respectively. Furthermore, being HIV patients and rural resident increased the risk of developing anemia about twofold. In conclusion hematological abnormalities were observed before and after cervical cancer treatment, with significance increment after chemo-radiotherapy and surgery. As the stage of cancer advances, the risk of developing hematological abnormalities increases. Therefore, routine monitoring of hematological changes before and after treatment and screening for major risk factors are important for improved patients’ management.  \nKeywords Hematological change, Cervical cancer, Treatment, Gondar, Ethiopia  \n1Department of Hematology and Immunohematology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia. 2Department of Clinical Chemistry, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia. 3Department of Medical Parasitology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia. 4Department of Quality Assurance and Laboratory Management, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia. 􀀍 email: [mengeshad826@gmail.com](mengeshad826@gmail.com)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nCervical cancer is a prevalent gynecological cancer that originates from the abnormal multiplication and spread of cells aro","cbCait09dZN9lwTh","https://ap.wps.com/l/cbCait09dZN9lwTh","pdf",1649051,11,"English","# Abstract\n## Study aim\n## Methods\n## Hematological findings before vs after treatment\n## Risk factors and stage effects\n## Conclusion","[{\"question\":\"What was the main purpose of the study?\",\"answer\":\"To assess hematological toxicity in women with cervical cancer before and after initiation of treatment, using a retrospective cohort design.\"},{\"question\":\"Which statistical methods were used to compare and model hematological parameters?\",\"answer\":\"Descriptive statistics summarized data; Wilcoxon rank test compared median differences before and after treatment; logistic regression assessed independent associations between hematological abnormalities and variables.\"},{\"question\":\"How did hematological abnormalities change after treatment?\",\"answer\":\"After treatment, hemoglobin, white blood cell counts, and platelet counts were significantly lowered, while red cell distribution width increased. Anemia increased after treatment, and leucocytosis/thrombocytosis patterns shifted to leucopenia/thrombocytopenia.\"}]","Hematological changes in women with cervical cancer before and after cancer treatment: retrospective cohort study | PDF",1790023654,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c641ccdc21bfccba50db0f63724a3c2e.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/750bf775091f59a7980cadfaebe72030.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/93800190284dfe1fe01bb5c8d0e575d5.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c342d693d188f3d734d2f22ffebdd435.webp",980,1287]